Cerity Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.3M | Sell |
454,736
-2,279
| -0.5% | -$26.6K | 0.01% | 778 |
|
|
2025
Q1 | $3.4M | Sell |
457,015
-21,433
| -4% | -$159K | 0.01% | 887 |
|
|
2024
Q4 | $2.48M | Sell |
478,448
-215,969
| -31% | -$1.12M | 0.01% | 1012 |
|
|
2024
Q3 | $3.56M | Buy |
694,417
+256,933
| +59% | +$1.32M | 0.01% | 849 |
|
|
2024
Q2 | $1.58M | Sell |
437,484
-238,760
| -35% | -$864K | ﹤0.01% | 1020 |
|
|
2024
Q1 | $2.17M | Buy |
676,244
+540,592
| +399% | +$1.74M | 0.01% | 935 |
|
|
2023
Q4 | $665K | Buy |
+135,652
| New | +$665K | ﹤0.01% | 1146 |
|
|
2023
Q3 | – | Sell |
-211,241
| Closed | -$1.42M | – | 1393 |
|
|
2023
Q2 | $1.42M | Sell |
211,241
-8,547
| -4% | -$57.4K | 0.01% | 817 |
|
|
2023
Q1 | $1.94M | Buy |
219,788
+61,523
| +39% | +$543K | ﹤0.01% | 731 |
|
|
2022
Q4 | $1.21M | Sell |
158,265
-319
| -0.2% | -$2.44K | 0.01% | 649 |
|
|
2022
Q3 | $1.13M | Buy |
158,584
+77,427
| +95% | +$551K | 0.01% | 487 |
|
|
2022
Q2 | $656K | Buy |
81,157
+3,223
| +4% | +$26.1K | 0.01% | 659 |
|
|
2022
Q1 | $1.08M | Buy |
77,934
+25,534
| +49% | +$355K | 0.02% | 432 |
|
|
2021
Q4 | $1.47M | Sell |
52,400
-19,684
| -27% | -$552K | 0.02% | 369 |
|
|
2021
Q3 | $2.45M | Buy |
72,084
+4,731
| +7% | +$161K | 0.05% | 239 |
|
|
2021
Q2 | $2.75M | Buy |
67,353
+10,527
| +19% | +$430K | 0.06% | 223 |
|
|
2021
Q1 | $2.29M | Buy |
56,826
+12,054
| +27% | +$485K | 0.05% | 236 |
|
|
2020
Q4 | $2.65M | Sell |
44,772
-167
| -0.4% | -$9.87K | 0.08% | 179 |
|
|
2020
Q3 | $2.19M | Buy |
44,939
+40,156
| +840% | +$1.95M | 0.09% | 158 |
|
|
2020
Q2 | $231K | Buy |
+4,783
| New | +$231K | 0.01% | 396 |
|